Boosting Functional Avidity of CD8+ T Cells by Vaccinia Virus Vaccination Depends on Intrinsic T-Cell MyD88 Expression but Not the Inflammatory Milieu-Reference-Cited by-同舟云学术

Boosting Functional Avidity of CD8+ T Cells by Vaccinia Virus Vaccination Depends on Intrinsic T-Cell MyD88 Expression but Not the Inflammatory Milieu

Published:2014-02-19 Issue:10 Volume:88 Page:5356-5368
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Hu Z.,Wang J.,Wan Y.,Zhu L.,Ren X.,Qiu S.,Ren Y.,Yuan S.,Ding X.,Chen J.,Qiu C.,Sun J.,Zhang X.,Xiang J.,Qiu C.,Xu J.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference45 articles.

1. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses;Harari;J. Exp. Med.,2008

2. Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara;Sandstrom;J. Infect. Dis.,2008

3. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-uninfected east Africans (RV 172);Kibuuka;J. Infect. Dis.,2010

4. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity;Ranasinghe;Expert Rev. Vaccines,2009

5. Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1;Paris;Expert Rev. Vaccines,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV vaccines induce CD8 ⁺ T cells with low antigen receptor sensitivity;Science;2023-12-15

2. Myeloid MyD88 restricts CD8+ T cell response to radiation therapy in pancreatic cancer;Scientific Reports;2023-05-27

3. Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors;Frontiers in Bioengineering and Biotechnology;2022-10-31

4. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development;Frontiers in Immunology;2022-06-23

5. Toll-Like Receptors in Adaptive Immunity;Toll-like Receptors in Health and Disease;2021